314 related articles for article (PubMed ID: 12891543)
21. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
22. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.
Moss AC; Anton P; Savidge T; Newman P; Cheifetz AS; Gay J; Paraschos S; Winter MW; Moyer MP; Karalis K; Kokkotou E; Pothoulakis C
Gut; 2007 Sep; 56(9):1210-7. PubMed ID: 17412781
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
25. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
26. NQO1-Knockout Mice Are Highly Sensitive to Clostridium Difficile Toxin A-Induced Enteritis.
Nam ST; Hwang JH; Kim DH; Lu LF; Hong J; Zhang P; Yoon IN; Hwang JS; Chung HK; Shong M; Lee CH; Kim H
J Microbiol Biotechnol; 2016 Aug; 26(8):1446-51. PubMed ID: 27116994
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
28. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins.
Pothoulakis C; Lamont JT
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G178-83. PubMed ID: 11208538
[TBL] [Abstract][Full Text] [Related]
29. [Clostridium difficile as an inducer of inflammatory diarrhea].
Rocha MF; Sidrim JJ; Lima AA
Rev Soc Bras Med Trop; 1999; 32(1):47-52. PubMed ID: 9927825
[TBL] [Abstract][Full Text] [Related]
30. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
31. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
[TBL] [Abstract][Full Text] [Related]
32. Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.
Toyokawa M; Ueda A; Tsukamoto H; Nishi I; Horikawa M; Sunada A; Asari S
J Infect Chemother; 2003 Dec; 9(4):351-4. PubMed ID: 14691659
[TBL] [Abstract][Full Text] [Related]
33. Toxin B Variants from
López-Ureña D; Orozco-Aguilar J; Chaves-Madrigal Y; Ramírez-Mata A; Villalobos-Jimenez A; Ost S; Quesada-Gómez C; Rodríguez C; Papatheodorou P; Chaves-Olarte E
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212980
[No Abstract] [Full Text] [Related]
34. Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants.
Blake JE; Mitsikosta F; Metcalfe MA
J Med Microbiol; 2004 Mar; 53(Pt 3):197-205. PubMed ID: 14970244
[TBL] [Abstract][Full Text] [Related]
35. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A.
Lee JY; Park HR; Oh YK; Kim YJ; Youn J; Han JS; Kim JM
J Mol Med (Berl); 2007 Dec; 85(12):1393-404. PubMed ID: 17639289
[TBL] [Abstract][Full Text] [Related]
36. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
[TBL] [Abstract][Full Text] [Related]
37. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
[TBL] [Abstract][Full Text] [Related]
38. Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.
Kokkotou E; Espinoza DO; Torres D; Karagiannides I; Kosteletos S; Savidge T; O'Brien M; Pothoulakis C
Gut; 2009 Jan; 58(1):34-40. PubMed ID: 18824554
[TBL] [Abstract][Full Text] [Related]
39. Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.
Androga GO; Hart J; Foster NF; Charles A; Forbes D; Riley TV
J Clin Microbiol; 2015 Nov; 53(11):3702-4. PubMed ID: 26354812
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
